Form 4: Harmony Biosciences Holdings Executive Sells Shares
Insider Transaction (Form 4)
Kumar Budur, CHIEF MEDICAL OFFICER of Harmony Biosciences Holdings, Inc., sold 33,954 shares of common stock on September 4, 2026.
Summary
- Open-market sale: disposed of 5,500 Common Stock at $41.98 ($230,911) on September 4, 2026; holds 18,615 after (Direct).
- Open-market sale: disposed of 4,500 Common Stock at $42.25 ($190,114) on September 8, 2026; holds 14,115 after (Direct).
- Open-market sale: disposed of 1,000 Common Stock at $42.79 ($42,795) on September 8, 2026; holds 13,115 after (Direct).
- Option exercise/conversion: acquired 12,200 Common Stock at $30.69 ($374,418) on September 8, 2026; holds 25,315 after (Direct).
- Option exercise/conversion: acquired 10,754 Common Stock at $30.27 ($325,524) on September 8, 2026; holds 36,069 after (Direct).
- Open-market sale: disposed of 22,954 Common Stock at $43.10 ($989,350) on September 8, 2026; holds 13,115 after (Direct).
- Option exercise/conversion: disposed of 12,200 Stock Option on September 8, 2026; holds 30,300 after (Direct).
- Option exercise/conversion: disposed of 10,754 Stock Option on September 8, 2026; holds 64,246 after (Direct).
Sentiment
Score: 3
Explanation: StockSavvy.ai views this as a mildly negative signal: an insider sold $1,453,169 of stock on the open market.
Insider Transactions
Kumar Budur — Officer (CHIEF MEDICAL OFFICER)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-04 | Open-market sale | Common Stock | 5,500 | $42 | $230.9K | 18,615 |
| 2026-09-08 | Open-market sale | Common Stock | 4,500 | $42 | $190.1K | 14,115 |
| 2026-09-08 | Open-market sale | Common Stock | 1,000 | $43 | $42.8K | 13,115 |
| 2026-09-08 | Option exercise/conversion | Common Stock | 12,200 | $31 | $374.4K | 25,315 |
| 2026-09-08 | Option exercise/conversion | Common Stock | 10,754 | $30 | $325.5K | 36,069 |
| 2026-09-08 | Open-market sale | Common Stock | 22,954 | $43 | $989.3K | 13,115 |
| 2026-09-08 | Option exercise/conversion | Stock Option | 12,200 | — | — | 30,300 |
| 2026-09-08 | Option exercise/conversion | Stock Option | 10,754 | — | — | 64,246 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-04 | Open-market sale (5,500 shares) |
| 2026-09-08 | Open-market sale (4,500 shares) |
| 2026-09-08 | Open-market sale (1,000 shares) |
| 2026-09-08 | Option exercise/conversion (12,200 shares) |
| 2026-09-08 | Option exercise/conversion (10,754 shares) |
| 2026-09-08 | Open-market sale (22,954 shares) |
| 2026-09-08 | Option exercise/conversion (12,200 shares) |
| 2026-09-08 | Option exercise/conversion (10,754 shares) |
Keywords
insider transaction, Form 4, HRMY, Harmony Biosciences Holdings, Inc., bearish, Kumar Budur
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.